Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.48 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | KDM4A | O75164 | 7/20 | 0.35 |
| ▸ | KDM4C | Q9H3R0 | 7/20 | 0.35 |
| ▸ | KDM5A | P29375 | 1/20 | 0.35 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.35 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.35 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2840617 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TSHRMAPTDNM1PAOX | |
| SCHEMBL1250791 | 0.92 | MAPT (0.58) | ALDH1A1TSHRMAPTDNM1PAOX | |
| SCHEMBL571030 | 0.92 | MAPT (0.58) | ALDH1A1TSHRMAPTDNM1PAOX | |
| SCHEMBL2847428 | 0.92 | MAPT (0.58) | ALDH1A1TSHRMAPTDNM1PAOX | |
| SCHEMBL4279258 | 0.91 | DNM1 (0.65) | ALDH1A1TSHRMAPTDNM1HSD17B10 | |
| SCHEMBL2843890 | 0.90 | ALDH1A1 (0.58) | ALDH1A1TSHRMAPTDNM1PAOX | |
| SCHEMBL2845499 | 0.90 | MAPT (0.55) | ALDH1A1TSHRMAPTDNM1PAOX | |
| SCHEMBL2843580 | 0.90 | ALDH1A1 (0.58) | ALDH1A1TSHRMAPTDNM1PAOX | |
| SCHEMBL29099399 | 0.87 | ALDH1A1 (0.55) | ALDH1A1TSHRMAPTDNM1PAOX | |
| SCHEMBL5989685 | 0.86 | ALDH1A1 (0.79) | ALDH1A1TSHRMAPTDNM1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10967325-B2 | Absorbent solution based on hydroxyl derivatives of 1,6-hexanediamine and method for eliminating acid compounds from a gaseous effluent | IFP Energies Nouvelles (FR) | 2021-04-06 | — | — | US | claimed |
| US-20200254380-A1 | ABSORBENT SOLUTION BASED ON HYDROXYL DERIVATIVES OF 1,6-HEXANEDIAMINE AND METHOD FOR ELIMINATING ACID COMPOUNDS FROM A GASEOUS EFFLUENT | IFP Energies Nouvelles (FR) | 2020-08-13 | — | — | US | claimed |
| EP-3389829-B1 | METHOD FOR ELIMINATING ACID COMPOUNDS FROM A GASEOUS EFFLUENT WITH AN ABSORBENT SOLUTION BASED ON HYDROXYL DERIVATIVES OF 1,6-HEXANEDIAMINE | IFP ENERGIES NOW (FR) | 2019-10-30 | — | — | EP | claimed |
| EP-3389829-A1 | ABSORBENT SOLUTION BASED ON HYDROXYL DERIVATIVES OF 1,6-HEXANEDIAMINE AND METHOD FOR ELIMINATING ACID COMPOUNDS FROM A GASEOUS EFFLUENT | IFP Energies nouvelles (FR) | 2018-10-24 | — | — | EP | claimed |
| WO-2017102746-A1 | ABSORBENT SOLUTION BASED ON HYDROXYL DERIVATIVES OF 1,6-HEXANEDIAMINE AND METHOD FOR ELIMINATING ACID COMPOUNDS FROM A GASEOUS EFFLUENT | IFP Energies Nouvelles (FR) | 2017-06-22 | — | — | WO | claimed |
| EP-1092737-B1 | Catalyst composition for the production of a polyurethane resin, and method for producing a polyurethane resin | TOSOH CORP (JP) | 2003-09-24 | — | — | EP | claimed |
| US-6596663-B1 | Reacting a polyol with an organic polyisocyanate in the presence of a diamine catalyst and, if necessary, a blowing agent, a surfactant, a cross-linking agent | TOSOH CORPORATION (JP) | 2003-07-22 | — | — | US | claimed |
| EP-1092737-A2 | Catalyst composition for the production of a polyurethane resin, and method for producing a polyurethane resin | Tosoh Corporation (JP) | 2001-04-18 | — | — | EP | claimed |
| US-20240255403-A1 | POLYURETHANE-CONTAINING NON-FOAMED MOLDED BODY | CANON KABUSHIKI KAISHA (JP) | 2024-08-01 | — | — | US | disclosed |
| EP-4397466-A1 | POLYURETHANE-CONTAINING NON-FOAMED MOLDED BODY | CANON KABUSHIKI KAISHA (JP) | 2024-07-10 | — | — | EP | disclosed |
| WO-2023032827-A1 | POLYURETHANE-CONTAINING NON-FOAMED MOLDED BODY | キヤノン株式会社 | 2023-03-09 | — | — | WO | disclosed |
| US-10967325-B2 | Absorbent solution based on hydroxyl derivatives of 1,6-hexanediamine and method for eliminating acid compounds from a gaseous effluent | IFP Energies Nouvelles (FR) | 2021-04-06 | — | — | US | disclosed |
| US-10967325-B2 | Absorbent solution based on hydroxyl derivatives of 1,6-hexanediamine and method for eliminating acid compounds from a gaseous effluent | IFP Energies Nouvelles (FR) | 2021-04-06 | — | — | US | disclosed |
| EP-3390344-B1 | IMPROVED METHOD FOR SYNTHESISING PARTIALLY N-HYDROXYETHYLATED TERTIARY 1,6-HEXANEDIAMINES | IFP ENERGIES NOW (FR) | 2020-12-02 | — | — | EP | disclosed |
| EP-2050775-A1 | CATALYST COMPOSITION FOR POLYURETHANE RESIN PRODUCTION AND METHOD FOR PRODUCING POLYURETHANE RESIN | Tosoh Corporation (JP) | 2009-04-22 | — | — | EP | disclosed |
| EP-1092737-B1 | Catalyst composition for the production of a polyurethane resin, and method for producing a polyurethane resin | TOSOH CORP (JP) | 2003-09-24 | — | — | EP | disclosed |
| US-20030144371-A1 | Catalyzing the copolymerization in presence of imidazole compounds, free of tin comound, forming polyetherurethane copolymers | TOSOH CORPORATION (JP) | 2003-07-31 | — | — | US | disclosed |
| US-6596663-B1 | Reacting a polyol with an organic polyisocyanate in the presence of a diamine catalyst and, if necessary, a blowing agent, a surfactant, a cross-linking agent | TOSOH CORPORATION (JP) | 2003-07-22 | — | — | US | disclosed |
| EP-1312630-A1 | Process for the production of flexible polyurethane foams | Tosoh Corporation (JP) | 2003-05-21 | — | — | EP | disclosed |
| EP-1092737-A2 | Catalyst composition for the production of a polyurethane resin, and method for producing a polyurethane resin | Tosoh Corporation (JP) | 2001-04-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10967325-B2 | Absorbent solution based on hydroxyl derivatives of 1,6-hexanediamine and method for eliminating acid compounds from a gaseous effluent | HAAO, HPD, ALKBH1 | ALDH1A1 28/4885TSHR 2614/4885MAPT 4516/4885 |
| US-20200254380-A1 | ABSORBENT SOLUTION BASED ON HYDROXYL DERIVATIVES OF 1,6-HEXANEDIAMINE AND METHOD FOR ELIMINATING ACID COMPOUNDS FROM A GASEOUS EFFLUENT | HAAO, HPD, ALKBH1 | ALDH1A1 28/4885TSHR 2614/4885MAPT 4516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.